Researchers at the University of Waterloo have developed a new system that could significantly speed up the discovery of new drugs and reduce the need for costly and time-consuming laboratory tests.
The new technology called Pattern to Knowledge (P2K) can predict the binding of biosequences in seconds and potentially reduce bottlenecks in drug research.
P2K uses artificial intelligence (AI) to leverage deep knowledge from data instead of relying solely on classical machine learning.
“P2K is a game changer given its ability to reveal subtle protein associations entangled in complex physiochemical environments and powerfully predict interactions based only on sequence data,” said Andrew Wong, professor, Systems Design Engineering, and Founding Director, Centre for Pattern Analysis and Machine Intelligence (CPAMI). “The ability to access this deep knowledge from proven scientific results will shift biological research going forward. P2K has the power to transform how data could be used in the future.”
Although a large amount of biological sequence data has been collected, extracting meaningful and useful knowledge hasn’t been easy. P2K algorithms tackle this challenge by disentangling multiple associations to identify and predict amino acid bindings that govern protein interactions. Since P2K is much faster than existing biosequence analysis software with almost 30 per cent better prediction accuracy, it could significantly speed up the discovery of new drugs. By drawing information from databases in the Cloud, P2K could predict how tumour proteins and potential cancer treatments would interact.
Although still in the early prototype stage, Professor Wong and his team have made the online P2K system available publicly to researchers to start identifying new bio-sequence interactions.
“Putting this AI technology in the hands of biomedical researchers will generate immediate results, which could be used for future scientific discoveries,” said Antonio Sze-To, research associate, Systems Design Engineering, and co-inventor of P2K.
Since it analyzes sequential data, the applicability of P2K isn’t limited to biomedical research. P2K could benefit the financial industry by making useful associations and predictions for smart trading or the cybersecurity sector by predicting the likelihood of a potential cyber attack.
The Latest on: Drug discovery
via Google News
The Latest on: Drug discovery
- 4th Drug Discovery Re-Invented Conference, Bahamas, 2019 on February 19, 2019 at 4:07 pm
The fourth Drug Discovery Re-Invented Meeting brings together experts in medicinal chemistry, structure-based drug design, computational chemistry, emerging drug targets, and novel technology platform... […]
- Police: K9 leads to discovery of heroin hidden in Spackle on February 19, 2019 at 2:22 pm
AMITY TWP., Pa. - Two Philadelphia men are behind bars in Berks County, thanks, in part, to the work of a drug-sniffing police dog. Juan Leon and Rafael Reyes were arrested Friday night after state po... […]
- Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute Invite Applications for 2019 ADDF-Harrington Scholar Award on February 19, 2019 at 12:49 pm
CLEVELAND, Feb. 19, 2019 /PRNewswire/ -- Harrington Discovery Institute at University Hospitals and the Alzheimer's Drug Discovery Foundation (ADDF) announce a joint request for proposals for the 2019 ... […]
- Drug Discovery Outsourcing Market 2019: By Charles River, Domainex, EVOTEC, GenScript, GVK Biosciences, Laboratory Corporation of America on February 19, 2019 at 12:05 pm
In this report, we analyze the Drug Discovery Outsourcing industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyz... […]
- Cancer Immunotherapy Drug Discovery Outsourcing Market Worth $1.7 Billion by 2025: Grand View Research, Inc. on February 19, 2019 at 2:52 am
SAN FRANCISCO, Feb. 19, 2019 /PRNewswire/ -- The global cancer immunotherapy drug discovery outsourcing market size is projected to reach USD 1.7Billion by 2025, according to a new report by Grand ... […]
- Light-based production of drug-discovery molecules on February 18, 2019 at 8:04 am
Photoelectrochemical (PEC) cells are widely studied for the conversion of solar energy into chemical fuels. They use photocathodes and photoanodes to "split" water into hydrogen and oxygen ... […]
- Global Drug Discovery Informatics market detailed in new research report on February 18, 2019 at 2:15 am
Submitted by RNR Market Research. Key players in drug discovery informatics market are IBM (US), Infosys (India), Schrödinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US). These players f... […]
- Open-science model for drug discovery expands to neurodegenerative diseases on February 15, 2019 at 12:37 pm
Parkinson's disease and Amyotrophic Lateral Sclerosis are the newest frontiers for open science drug discovery, a global movement led by academic scientists in Toronto that puts knowledge sharing ... […]
- A depression drug that's been called 'the most important discovery in half a century' just got a big step closer to FDA approval (JNJ) on February 12, 2019 at 11:51 am
A drug inspired by ketamine, which has been called "the most important discovery in half a century," is on the cusp of becoming the first new kind of depression medication in 35 years. Called ... […]
via Bing News